Surgically confirmed severe endometriosis is associated with lower risk of steatotic liver disease: Evidence of estrogen‐linked hepatic–reproductive crosstalk

OBJECTIVE: The prevalence of steatotic liver disease (SLD) is increasing globally. Endometriosis, affecting up to 10% of women, is a major cause of infertility. While associations between endometriosis and metabolic syndrome have been reported, its relationship with SLD remains unclear. Our study aimed to evaluate the association between endometriosis severity and SLD. METHODS: We retrospectively analyzed women who underwent surgery for endometriosis with documented revised American Society for Reproductive Medicine scores at a tertiary hospital (January 1, 2009, to February 28, 2025) and had undergone abdominal computed tomography (CT) within 6 months as part of the clinical evaluation for endometriosis. Hepatic steatosis was assessed on abdominal CT using the liver-to-spleen Hounsfield unit (LS) ratio with predefined cutoff values, where lower values indicate greater hepatic fat accumulation, and SLD and severe SLD were defined as LS